Discovery of XRF-1021, a 2,4-disubstituted-5-fluoropyrimidine derivative as a homeodomain-interacting protein kinase 2 inhibitor for the treatment of chronic kidney diseaseXinlan Hu, Qianbin Li, Songsen Fu et al.|European Journal of Medicinal Chemistry|2025Cited by 1